BUY Eureka Forbes Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)28 Nov 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·14 Aug · 2mo ago
Nothing found in this tip’s window yet.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·21 Oct · yesterday
The company received a show cause notice from Uttar Pradesh GST authorities.
NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·1 Oct · 3w ago
Eureka Forbes receives ₹273 crore GST show-cause notice from Uttar Pradesh tax authority
NewsCnbc-Tv18·28 Sept · 3w ago
Eureka Forbes received a GST show cause notice from Uttar Pradesh authorities for FY 2022-23, demanding Rs 273.40 crore including interest and penalties. The company intends to contest the notice.
NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·28 Sept · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Eureka Forbes
- BUY — Nuvama Wealth14 Aug 2026 · ~1 year · target ₹720 · Active
- BUY — Nomura India Research14 Aug 2026 · ~1 year · target ₹572 · Active
- BUY — Elara Capital13 Aug 2026 · ~1 year · target ₹630 · Active
- BUY — Sandeep Jain, Tradeswift14 Jul 2026 · ~2 weeks · target ₹570 · Expired
- BUY — ICICI Securities16 Nov 2025 · ~1 year · target ₹685 · Active
More from ICICI Securities
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active
- BUY Crompton Greaves Consumer Electricals19 Oct 2026 · ~1 year · target ₹275 · Active

